| PET imaging of amyloid deposition in patients with mild cognitive impairment A Forsberg, H Engler, O Almkvist, G Blomquist, G Hagman, A Wall, ... Neurobiology of aging 29 (10), 1456-1465, 2008 | 830 | 2008 |
| Two-year follow-up of amyloid deposition in patients with Alzheimer's disease H Engler, A Forsberg, O Almkvist, G Blomquist, E Larsson, I Savitcheva, ... Brain 129 (11), 2856-2866, 2006 | 766 | 2006 |
| Brain glial activation in fibromyalgia–A multi-site positron emission tomography investigation DS Albrecht, A Forsberg, A Sandström, C Bergan, D Kadetoff, E Protsenko, ... Brain, behavior, and immunity 75, 72-83, 2019 | 281 | 2019 |
| Clinical validation of 18F-AZD4694, an amyloid-β–specific PET radioligand Z Cselényi, ME Jönhagen, A Forsberg, C Halldin, P Julin, M Schou, ... Journal of Nuclear Medicine 53 (3), 415-424, 2012 | 250 | 2012 |
| A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease A Nordberg, SF Carter, J Rinne, A Drzezga, DJ Brooks, R Vandenberghe, ... European journal of nuclear medicine and molecular imaging 40, 104-114, 2013 | 222 | 2013 |
| Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease A Kadir, O Almkvist, A Forsberg, A Wall, H Engler, B Långström, ... Neurobiology of aging 33 (1), 198. e1-198. e14, 2012 | 190 | 2012 |
| Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease A Kadir, N Andreasen, O Almkvist, A Wall, A Forsberg, H Engler, ... Annals of neurology 63 (5), 621-631, 2008 | 161 | 2008 |
| High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters A Forsberg, O Almkvist, H Engler, A Wall, B Langstrom, A Nordberg Current Alzheimer Research 7 (1), 56-66, 2010 | 111 | 2010 |
| Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C] PBR28 K Collste, P Plavén-Sigray, H Fatouros-Bergman, P Victorsson, M Schain, ... Molecular psychiatry 22 (6), 850-856, 2017 | 109 | 2017 |
| Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s disease patients G Paul, O Zachrisson, A Varrone, P Almqvist, M Jerling, G Lind, ... The Journal of clinical investigation 125 (3), 1339-1346, 2015 | 102 | 2015 |
| The immune response of the human brain to abdominal surgery A Forsberg, S Cervenka, M Jonsson Fagerlund, LS Rasmussen, ... Annals of neurology 81 (4), 572-582, 2017 | 100 | 2017 |
| Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects K Collste, A Forsberg, A Varrone, N Amini, S Aeinehband, I Yakushev, ... European journal of nuclear medicine and molecular imaging 43, 173-183, 2016 | 94 | 2016 |
| Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease E Stefanova, A Wall, O Almkvist, A Nilsson, A Forsberg, B Långström, ... Journal of neural transmission 113, 205-218, 2006 | 90 | 2006 |
| Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [11C]PBR28 HRRT PET study J Tuisku, P Plavén-Sigray, EC Gaiser, L Airas, H Al-Abdulrasul, A Brück, ... European journal of nuclear medicine and molecular imaging 46, 2329-2338, 2019 | 85 | 2019 |
| In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients A Varrone, P Mattsson, A Forsberg, A Takano, S Nag, B Gulyás, J Borg, ... European journal of nuclear medicine and molecular imaging 40, 921-931, 2013 | 85 | 2013 |
| Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects A Varrone, V Oikonen, A Forsberg, J Joutsa, A Takano, O Solin, ... European Journal of Nuclear Medicine and Molecular Imaging 42, 438-446, 2015 | 84 | 2015 |
| Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo T Darreh-Shori, A Forsberg, N Modiri, N Andreasen, K Blennow, C Kamil, ... Neurobiology of aging 32 (12), 2320. e15-2320. e32, 2011 | 74 | 2011 |
| Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients C Keller, A Kadir, A Forsberg, O Porras, A Nordberg Journal of Alzheimer's Disease 24 (1), 109-123, 2011 | 70 | 2011 |
| The use of PIB-PET as a dual pathological and functional biomarker in AD A Forsberg, H Engler, G Blomquist, B Långström, A Nordberg Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (3), 380-385, 2012 | 68 | 2012 |
| Unidirectional influx and net accumulation of PIB G Blomquist, H Engler, A Nordberg, A Ringheim, A Wall, A Forsberg, ... The open neuroimaging journal 2, 114, 2008 | 63 | 2008 |
